Mursla, a UK-based oncology-focused spinout of Tokyo Institute of Technology (TIT), has partnered University of Cambridge to build a prototype of its diagnostic technology, Business Weekly reported on Tuesday.
The spinout will be based at University of Cambridge’s IdeaSpace innovation hub, which generally offers its services to any early-stage spinout or startup based in Cambridge. IdeaSpace offers access to the university’s links with other faculties, governments and agencies.
Mursla has developed diagnostic liquid biopsy nanostructures to better analyse the health…
